CBD, Companies, Food & Drink, HT Premium, News, Regulatory

FDA warns 3 U.S. CBD sellers over ‘egregious’ cancer claims

Breaking news from HempToday, the voice of the global hemp industries.
Share this:
  • 191

The U.S Food & Drug Administration (FDA) and the Federal Trade Commission jointly issued warning letters to three American companies for unsubstantiated claims regarding CBD. The claims are carried in online platforms operated by the companies as well as social media, FDA said.

You need to login to view the rest of the content. Please . Not a Member? Join Us

Get Hemp Industry Updates

* indicates required

Do you want event updates?